{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:17:45Z","timestamp":1785370665988,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A4A1042399"],"award-info":[{"award-number":["2015R1A4A1042399"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A4A1042399"],"award-info":[{"award-number":["2015R1A4A1042399"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00773","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T04:47:46Z","timestamp":1531716466000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro"],"prefix":"10.3389","volume":"9","author":[{"given":"Dong-Hyun","family":"Youn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Lin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunu","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JongWook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seona","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gahee","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jeong","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2165\/00002018-200932080-200932083","article-title":"Serenoa repens (saw palmetto).","volume":"32","author":"Agbabiaka","year":"2009","journal-title":"Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.steroids.2009.10.005","article-title":"An overview on 5\u03b1-reductase inhibitors.","volume":"75","author":"Aggarwal","year":"2010","journal-title":"Steroids"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1158\/0008-5472.CAN-04-3541","article-title":"Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.","volume":"65","author":"Agoulnik","year":"2005","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.","volume":"92","author":"Amory","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/01.ju.0000139539.94828.29","article-title":"Dihydrotestosterone and the prostate: the scientific rationale for 5\u03b1-reductase inhibitors in the treatment of benign prostatic hyperplasia.","volume":"172","author":"Andriole","year":"2004","journal-title":"J. Urol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0090-4295(91)80191-9","article-title":"Natural history of benign prostatichyperplasia and risk of prostatectomy: the Baltimore longitudinal study of aging.","volume":"38","author":"Arrighi","year":"1991","journal-title":"Urology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1210\/jcem.86.6.7545","article-title":"5\u03b1-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro.","volume":"86","author":"Asada","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B8","first-page":"14","article-title":"Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management.","author":"Barkin","year":"2011","journal-title":"Can. J. Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/carcin\/18.6.1215","article-title":"Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.","volume":"18","author":"Bello","year":"1997","journal-title":"Carcinogenesis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age.","volume":"132","author":"Berry","year":"1984","journal-title":"J. Urol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1590\/S0100-879X2000000200004","article-title":"Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents).","volume":"33","author":"Calixto","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/srep31906","article-title":"Cinnamomi cortex (Cinnamomum verum) suppresses testosterone-induced benign prostatic hyperplasia by regulating 5\u03b1-reductase.","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.31","article-title":"Benign prostatic hyperplasia.","volume":"2","author":"Chughtai","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5\u03b1-reductase inhibitor.","volume":"89","author":"Clark","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C","article-title":"Regulation of prostatic growth and function by peptide growth factors.","volume":"28","author":"Culig","year":"1996","journal-title":"Prostate"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000019919","article-title":"A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.","volume":"36","author":"Djavan","year":"1999","journal-title":"Eur. Urol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOU.0b013e32834100dd","article-title":"Benign prostate hyperplasia: a review of the year\u2019s progress from bench to clinic.","volume":"21","author":"Donnell","year":"2011","journal-title":"Curr. Opin. Urol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.celrep.2015.07.011","article-title":"Functional redundancy of ERK1 and ERK2 MAP kinases during development.","volume":"12","author":"Fr\u00e9min","year":"2015","journal-title":"Cell Rep."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/srep43771","article-title":"Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.","volume":"7","author":"Fu","year":"2017","journal-title":"Sci. Rep."},{"key":"B20","first-page":"303","article-title":"Mitogen-activated protein\/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.","volume":"1","author":"Fukazawa","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"14477","DOI":"10.1073\/pnas.0606836103","article-title":"Combinatorial activities of Akt and B-Raf\/Erk signaling in a mouse model of androgen-independent prostate cancer.","volume":"103","author":"Gao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","first-page":"S99","article-title":"An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.","volume":"12","author":"Gilbert","year":"2006","journal-title":"Am. J. Manag. Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","article-title":"The effect of finasteride in men with benign prostatic hyperplasia.","volume":"327","author":"Gormley","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00345-009-0493-y","article-title":"Current status of 5\u03b1-reductase inhibitors in the management of lower urinary tract symptoms and BPH.","volume":"28","author":"Gravas","year":"2010","journal-title":"World J. Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/edrv.23.2.0460","article-title":"Androgen receptor (AR) coregulators: an overview.","volume":"23","author":"Heinlein","year":"","journal-title":"Endocr. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1210\/me.2002-2070","article-title":"The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.","volume":"16","author":"Heinlein","year":"","journal-title":"Mol. Endocrinol."},{"key":"B27","first-page":"1051","article-title":"Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.","volume":"53","author":"Henttu","year":"1993","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5487\/TR.2010.26.2.109","article-title":"Berberine inhibited radioresistant effects and enhanced anti-tumor effects in the irradiated-human prostate cancer cells.","volume":"26","author":"Hur","year":"2010","journal-title":"Toxicol. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.eururo.2006.06.012","article-title":"The efficacy of drugs for the treatment of LUTS\/BPH, a study in 6 European countries.","volume":"51","author":"Hutchison","year":"2007","journal-title":"Eur. Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.ajpath.2013.02.028","article-title":"Androgen receptor roles in the development of benign prostate hyperplasia.","volume":"182","author":"Izumi","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj1954.12.1","article-title":"Basic studies on the prostate of rat under various hormonal environment.","volume":"12","author":"Kato","year":"1965","journal-title":"Endocrinol. Jpn."},{"key":"B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13273-016-0008-z","article-title":"Berberine-induced changes in protein expression and antioxidant enzymes in melanoma cells.","volume":"12","author":"Kim","year":"2016","journal-title":"Mol. Cell. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13273-016-0023-0","article-title":"Protective effects of garlic oil against 1, 3-dichloro-2-propanol-induced hepatotoxicity: role of CYP2E1 and MAPKs.","volume":"12","author":"Ko","year":"2016","journal-title":"Mol. Cell. Toxicol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pros.10084","article-title":"Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.","volume":"52","author":"Kramer","year":"2002","journal-title":"Prostate"},{"key":"B35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/pros.10340","article-title":"Dutasteride, the dual 5\u03b1\u2013reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.","volume":"58","author":"Lazier","year":"2004","journal-title":"Prostate"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-10-0985","article-title":"Berberine suppresses androgen receptor signaling in prostate cancer.","volume":"10","author":"Li","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191469","article-title":"Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms.","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.yexcr.2004.05.006","article-title":"Unbalanced activation of ERK1\/2 and MEK1\/2 in apigenin-induced HeLa cell death.","volume":"299","author":"Llorens","year":"2004","journal-title":"Exp. Cell Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0022-5347(17)62763-0","article-title":"The incidence of benign prostatic obstruction.","volume":"99","author":"Lytton","year":"1968","journal-title":"J. Urol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0306-3623(89)90271-1","article-title":"Infravesical outflow obstruction in rats: a comparison of two models.","volume":"20","author":"Maggi","year":"1989","journal-title":"Gen. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.21010\/ajtcam.v13i6.27","article-title":"Emodin efficacy on the Akt, MAPK, ERK and DNMT expression pattern during DMBA-induced oral carcinoma in golden syrian hamsters.","volume":"13","author":"Manimaran","year":"2016","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1093\/emboj\/19.20.5406","article-title":"Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.","volume":"19","author":"Migliaccio","year":"2000","journal-title":"EMBO J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S1471-4914(01)02015-9","article-title":"Molecular \u2018palpation\u2019of BPH: a tale of MAPK signalling?","volume":"7","author":"Papatsoris","year":"2001","journal-title":"Trends Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/1535-7163.MCT-06-0610","article-title":"The power and promise of \u201crewiring\u201d the mitogen-activated protein kinase network in prostate cancer therapeutics.","volume":"6","author":"Papatsoris","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopha.2017.07.015","article-title":"The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models.","volume":"94","author":"Park","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/sj.onc.1203032","article-title":"Rapid signalling by androgen receptor in prostate cancer cells.","volume":"18","author":"Peterziel","year":"1999","journal-title":"Oncogene"},{"key":"B47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.sbi.2016.07.019","article-title":"MAPK kinase signalling dynamics regulate cell fate decisions and drug resistance.","volume":"41","author":"Rauch","year":"2016","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B48","first-page":"447","article-title":"Inhibition of genistein on the proliferation of RWPE-1 cells induced by testosterone under the control of insulin-like growth factor-1.","volume":"39","author":"Ren","year":"2010","journal-title":"Wei Sheng Yan Jiu"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.juro.2011.11.081","article-title":"Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.","volume":"187","author":"Rick","year":"2012","journal-title":"J. Urol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ijir.2008.55","article-title":"Pathology of benign prostatic hyperplasia.","volume":"20","author":"Roehrborn","year":"2008","journal-title":"Int. J. Impot. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/01.ju.0000112918.74410.94","article-title":"Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.","volume":"171","author":"Roehrborn","year":"2004","journal-title":"J. Urol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1464-410X.2007.07061.x","article-title":"The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics.","volume":"100","author":"Roehrborn","year":"2007","journal-title":"BJU Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.18632\/oncotarget.2953","article-title":"Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.","volume":"6","author":"Rybak","year":"2015","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.fertnstert.2013.07.2000","article-title":"Finasteride use in the male infertility population: effects on semen and hormone parameters.","volume":"100","author":"Samplaski","year":"2013","journal-title":"Fertil. Steril."},{"key":"B55","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.devcel.2007.03.009","article-title":"Mek1\/2 MAPK kinases are essential for mammalian development, homeostasis, and raf-induced hyperplasia.","volume":"12","author":"Scholl","year":"2007","journal-title":"Dev. Cell"},{"key":"B56","first-page":"439","article-title":"The effect of different doses of finasteride on sperm morphology and motility and reactive oxygen species concentrations in rats.","volume":"77","author":"Serga","year":"2009","journal-title":"Med. J. Cairo Univ."},{"key":"B57","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade.","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0022-5347(17)37546-8","article-title":"The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.","volume":"147","author":"Shapiro","year":"1992","journal-title":"J. Urol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-12-48","article-title":"Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.","volume":"12","author":"Shin","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","article-title":"Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue.","volume":"83","author":"Steiner","year":"2003","journal-title":"Lab. Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1172\/JCI116665","article-title":"Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.","volume":"92","author":"Thigpen","year":"1993","journal-title":"J. Clin. Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4103\/1008-682X.169997","article-title":"Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.","volume":"18","author":"Tian","year":"2016","journal-title":"Asian J. Androl."},{"key":"B63","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.1074\/jbc.M010384200","article-title":"MAPK\/ERK overrides the apoptotic signaling from fas, TNF, and TRAIL receptors.","volume":"276","author":"Tran","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.3390\/ijms140611034","article-title":"Current status of biomarkers for prostate cancer.","volume":"14","author":"Velonas","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13273-016-0006-1","article-title":"Effects of compounds isolated from a Litsea japonica fruit extract on the TNF-\u03b1 signaling pathway and cell viability.","volume":"12","author":"Won","year":"2016","journal-title":"Mol. Cell. Toxicol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1042\/CS20170030","article-title":"Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.","volume":"131","author":"Xu","year":"2017","journal-title":"Clin. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.18632\/oncotarget.13430","article-title":"Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5alpha-reductase and extracellular signal-regulated kinase.","volume":"8","author":"Youn","year":"2017","journal-title":"Oncotarget"},{"key":"B68","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/pros.20722","article-title":"The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK.","volume":"68","author":"Zhang","year":"2008","journal-title":"Prostate"}],"updated-by":[{"DOI":"10.3389\/fphar.2019.00541","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T07:46:35Z","timestamp":1558511195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":68,"alternative-id":["10.3389\/fphar.2018.00773"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00773","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2019.00541","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"article-number":"773"}}